Luis Meza

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Acute Lymphoblastic Leukemia

Circulating Tumor

Top Venues

Cancer discovery

Nature medicine

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery 14 (7) (2024)
Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery 14 (7) (2024)
Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery (2024)
Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery 14 (7) (2024)
Luis Meza, Zeynep Zengin, Sabrina Salgia, Jasnoor Malhotra, Ewa Karczewska, Tanya Barauskas Dorff, Abhishek Tripathi, Jennifer Ely, Erin Kelley, Heather Mead, Jo Ann Hsu, Nazli Dizman, Nicholas Salgia, Neal Chawla, Alex Chehrazi-Raffle, Ramya Muddasani, Ameish Govindarajan, Adam Rock, Sandy Liu, Ravi Salgia, Jeffrey Trent, John Altin, Sumanta K Pal
Twelve-Month Follow-up of the Immune Response After COVID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort Analysis. The oncologist (2023)
Luis Meza, David F McDermott, Bernard Escudier, Thomas E Hutson, Camillo Porta, Elena Verzoni, Michael B Atkins, Vijay Kasturi, Sumanta K Pal, Brian Rini
Tivozanib in Patients with Advanced Renal Cell Carcinoma Previously Treated With Axitinib: Subgroup Analysis from TIVO-3. The oncologist 28 (3) (2023)
Alexander Chehrazi-Raffle, Sally Leong, Sana Ali, Tane Kim, Sam Melamed, Xiaochen Li, Zeynep Zengin, Luis Meza, Neal Chawla, Ameish Govindarajan, Daniela Castro, Benjamin Mercier, Hedyeh Ebrahimi, Nazli Dizman, Nishita Tripathi, Nicolas Sayegh, Adam Rock, James Yeh, Sumanta K Pal, Mykola Onyshchenko
Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell Carcinoma. The oncologist (2023)
Luis Meza, David F McDermott, Bernard Escudier, Thomas E Hutson, Camillo Porta, Elena Verzoni, Michael B Atkins, Vijay Kasturi, Sumanta K Pal, Brian Rini
Tivozanib in Patients with Advanced Renal Cell Carcinoma Previously Treated With Axitinib: Subgroup Analysis from TIVO-3. The oncologist (2022)
Nazli Dizman, Luis Meza, Paulo Bergerot, Marice Alcantara, Tanya Dorff, Yung Lyou, Paul Frankel, Yujie Cui, Valerie Mira, Marian Llamas, Joann Hsu, Zeynep Zengin, Nicholas Salgia, Sabrina Salgia, Jasnoor Malhotra, Neal Chawla, Alex Chehrazi-Raffle, Ramya Muddasani, John Gillece, Lauren Reining, Jeff Trent, Motomichi Takahashi, Kentaro Oka, Seiya Higashi, Marcin Kortylewski, Sarah K Highlander, Sumanta Kumar Pal
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial. Nature medicine 28 (4) (2022)
Luis Meza, Ameish Govindarajan, Matthew Feng, Sumanta Kumar Pal
Live bacterial supplementation for improving treatment response in metastatic renal cell carcinoma. Clinical and translational medicine 12 (7) (2022)
Zeynep B Zengin, Caroline Weipert, Nicholas J Salgia, Nazli Dizman, Joann Hsu, Luis Meza, Alexander Chehrazi-Raffle, Ramya Muddasani, Sabrina Salgia, Jasnoor Malhotra, Neal S Chawla, Errol J Philip, Lesli A Kiedrowski, Benjamin L Maughan, Nityam Rathi, Divyam Goel, Toni K Choueiri, Archana M Agarwal, Sumanta K Pal
Complementary Role of Circulating Tumor DNA Assessment and Tissue Genomic Profiling in Metastatic Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (17) (2021)
Nazli Dizman, Luis Meza, Sumanta K Pal
Biomarker approach harnessed in trials of personalized medicine for bladder cancer. Nature medicine 27 (5) (2021)
Luis Meza, Jasnoor Malhotra, Crystal Favorito, Sumanta Kumar Pal
Cabozantinib plus immunotherapy combinations in metastatic renal cell and urothelial carcinoma. Future oncology (London, England) 18 (1) (2021)